Jack D. Blaine, M.D.
Chief, Treatment Research Branch
Division of Clinical and Services Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Bethesda, Maryland 20892 (301) 443-0107; Fax: (301) 443-8674
E-mail: jack_blaine@nih.gov

Shirley D. Coletti, D.H.L.
President, Operation PAR, Inc.
10901-C Roosevelt Boulevard, Suite 1000
St. Petersburg, FL 33716
(813) 570-5080; Fax: (813) 570-5083
E-mail: pdonalds@nurse.hsc.usf.edu

Bennett W. Fletcher, Ph.D.
Chief, Services Research Branch
Division of Clinical and Services Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Bethesda, Maryland 20892 (301) 443-4060; Fax: (301) 443-6815
E-mail: bf31v@nih.gov

Allan W. Graham, M.D.
Chemical Dependency Treatment Services
Kaiser Permanente
10350 East Dakota Avenue, Suite C
Denver, CO 80231
(303) 367-2812; Fax: (303) 367-2828
E-mail: Allan.W.Graham@kp.org

John S. Gustafson
Executive Director
National Association of State Alcohol and Drug Abuse Directors, Inc.
808 17th Street, NW, Suite 410
Washington, DC 20006
(202) 293-0090; Fax: (202) 293-1250
E-mail: dcoffice@nasadad.org

Linda P. Kaplan, CAE
Executive Director
National Association of Alcoholism and Drug Abuse Counselors
1911 North Fort Myer Drive, Suite 900
Arlington, VA 22209
(703) 741-7686; Fax: (703) 741-7698
E-mail: naadac@internetmci.com

Lisa S. Onken, Ph.D.
Associate Chief, Treatment Research Branch
Division of Clinical and Services Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Bethesda, Maryland 20892 (301) 443-0107; Fax: (301) 443-8674
E-mail: lo10n@nih.gov

Stephen R. Zukin, M.D.
Director, Division of Clinical and Services Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Bethesda, Maryland 20892 (301) 443-6697; Fax: (301) 443-2317
E-mail: szukin@helix.nih.gov

Special Thanks

Andrea Baruchin, Ph.D.
National Institute on Drug Abuse

L. Jeanne Borger
National Institute on Drug Abuse

Robyn Bowie-Semsker
Capital Consulting Corporation

Mark Brown
Capital Consulting Corporation

Mona Brown
National Institute on Drug Abuse

Lawrence S. Brown, Jr., M.D., M.P.H.*
Addiction Research and Treatment Corporation

James F. Callahan, D.P.A.
American Society of Addiction Medicine

John J. Campbell
Center for Substance Abuse Treatment

Marjorie Cashion, M.S.W.
Center for Substance Abuse Treatment

Timothy P. Condon, Ph.D.
National Institute on Drug Abuse

Dorynne J. Czechowicz, M.D.
National Institute on Drug Abuse

Charles J. Devlin
Therapeutic Communities of America

Thomas E. Feucht, Ph.D.
National Institute of Justice

Marian W. Fischman, Ph.D.*
Columbia University

Bennett W. Fletcher, Ph.D.
National Institute on Drug Abuse

John S. Gustafson
National Association of State Alcohol and Drug Abuse Directors, Inc.

Morton E. Goldberg, D.Sc. (Ret.)*
ICI Pharmaceuticals Group and University of Pennsylvania

Perry N. Halkitis, Ph.D.
Gay Men's Health Crisis, Inc.

Reese T. Jones, M.D.*
University of California, San Francisco

Linda P. Kaplan, CAE
National Association of Alcoholism and Drug Abuse Counselors

Irwin J. Kopin, M.D.
American College of Neuropsychopharmacology and National Institute of Neurological Disorders and Stroke

Jan Lipkin
National Institute on Drug Abuse

Sloan Mahone
American Academy of Child and Adolescent Psychiatry

G. Alan Marlatt, Ph.D.*
University of Washington, Seattle

Ginna Marston
Partnership for a Drug-Free America

A. Thomas McLellan, Ph.D.*
University of Pennsylvania School of Medicine

Tracy Newell, M.S.W.
National Association of Social Workers

Joan Nolan
National Institute on Drug Abuse

Lisa S. Onken, Ph.D.*
National Institute on Drug Abuse

Kay Paine
Join Together

Mark W. Parrino, M.P.A.
American Methadone Treatment Association

Leon PoVey
National Association of State Alcohol and Drug Abuse Directors, Inc. and Utah State Division of Substance Abuse

Rafaela R. Robles, Ed.D.*
Mental Health and Anti-Addiction Services Administration

Sue Schlossberg
National Institute on Drug Abuse

Tanya Singer
Capital Consulting Corporation

Jack B. Stein, L.C.S.W.
National Institute on Drug Abuse

Richard T. Suchinsky, M.D.
Veterans Administration

Ivette Torres
Center for Substance Abuse Treatment

Jeanne G. Trumble, M.S.W.
American Academy of Addiction Psychiatry

Mark Weber
Substance Abuse and Mental Health Services Administration

Beth Weinman
Federal Bureau of Prisons

Linda R. Wolf Jones, D.S.W.
Therapeutic Communities of America

Beverly Wyckoff-Jackson
National Institute on Drug Abuse

Stephen R. Zukin, M.D.*
National Institute on Drug Abuse

* Member of the Treatment Subcommittee, NIDA National Advisory Council on Drug Abuse